Mertelsmann R - Search Results

1

A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma.

Chapman PB, Kolitz JE, Hakes TB, Gabrilove JL, Welte K, Merluzzi VJ, Engert A, Bradley EC, Konrad M, Mertelsmann R. Chapman PB, et al. Among authors: mertelsmann r. Invest New Drugs. 1988 Sep;6(3):179-88. doi: 10.1007/BF00175395. Invest New Drugs. 1988. PMID: 3263958

2

Interleukin 2: a review.

Kolitz JE, Welte K, Sykora KW, Mertelsmann R. Kolitz JE, et al. Among authors: mertelsmann r. Arzneimittelforschung. 1985;35(10):1607-15. Arzneimittelforschung. 1985. PMID: 3000391 Review.

3

Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow.

Welte K, Keever CA, Levick J, Bonilla MA, Merluzzi VJ, Mertelsmann R, Evans R, O'Reilly RJ. Welte K, et al. Among authors: mertelsmann r. Blood. 1987 Nov;70(5):1595-603. Blood. 1987. PMID: 3311208 Free article.

4

The immunotherapy of human cancer with interleukin 2: present status and future directions.

Kolitz JE, Mertelsmann R. Kolitz JE, et al. Among authors: mertelsmann r. Cancer Invest. 1991;9(5):529-42. doi: 10.3109/07357909109018951. Cancer Invest. 1991. PMID: 1933486 Review.

5

Pharmacokinetics of recombinant interleukin 2 in humans.

Konrad MW, Hemstreet G, Hersh EM, Mansell PW, Mertelsmann R, Kolitz JE, Bradley EC. Konrad MW, et al. Among authors: mertelsmann r. Cancer Res. 1990 Apr 1;50(7):2009-17. Cancer Res. 1990. PMID: 2317789

6

Human interleukin 2: molecular biology, physiology and clinical possibilities.

Mertelsmann R, Welte K. Mertelsmann R, et al. Immunobiology. 1986 Sep;172(3-5):400-19. doi: 10.1016/S0171-2985(86)80121-8. Immunobiology. 1986. PMID: 3100434 Review. No abstract available.

7

Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2.

Merluzzi VJ, Welte K, Savage DM, Last-Barney K, Mertelsmann R. Merluzzi VJ, et al. Among authors: mertelsmann r. J Immunol. 1983 Aug;131(2):806-9. J Immunol. 1983. PMID: 6134774

8

Lysis of spontaneous murine breast tumors by human interleukin 2-stimulated syngeneic T-lymphocytes.

Merluzzi VJ, Savage DM, Souza L, Boone T, Mertelsmann R, Welte K, Last-Barney K. Merluzzi VJ, et al. Among authors: mertelsmann r. Cancer Res. 1985 Jan;45(1):203-6. Cancer Res. 1985. PMID: 3871172

9

Human interleukin 2: biochemistry, physiology, and possible pathogenetic role in immunodeficiency syndromes.

Welte K, Mertelsmann R. Welte K, et al. Among authors: mertelsmann r. Cancer Invest. 1985;3(1):35-49. doi: 10.3109/07357908509040606. Cancer Invest. 1985. PMID: 3918772 Review. No abstract available.

10

Production and response to interleukin 2 in vitro and in vivo after bone marrow transplantation in mice.

Merluzzi VJ, Welte K, Last-Barney K, Mertelsmann R, Souza L, Boone T, Savage DM, Quinn D, O'Reilly RJ. Merluzzi VJ, et al. Among authors: mertelsmann r. J Immunol. 1985 Apr;134(4):2426-30. J Immunol. 1985. PMID: 3919093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters